Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Talitha L Feenstra

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Scientific Reports|September 2, 2016
Projecting the COPD population and costs in England and Scotland: 2011 to 2030Susannah McLean, Martine Hoogendoorn, Rudolf T Hoogenveen, et al.
BMC Primary Care|June 11, 2024
Effects of a multicomponent communication training to involve older people in decisions to DEPRESCRIBE cardiometabolic medication in primary care (CO-DEPRESCRIBE): protocol for a cluster randomized controlled trial with embedded process and economic evaluationPeter J C Stuijt, Mette Heringa, Liset van Dijk, et al.
Breast (Edinburgh, Scotland)|March 25, 2019
Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? - A cost-effectiveness analysisXuan-Anh Phi, Marcel J W Greuter, Inge-Marie Obdeijn, et al.
Cost Effectiveness and Resource Allocation : C/E|October 7, 2011
Targeted versus universal prevention. a resource allocation model to prioritize cardiovascular preventionTalitha L Feenstra, Pieter M van Baal, Monique O Jacobs-van der Bruggen, et al.
Pharmacoeconomics|June 21, 2024
Evaluating the Cost-Utility of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Systematic Review of the Methods and Quality of Studies Using Decision Models or Empirical DataLisa A de Jong, Xinyu Li, Sajad Emamipour, et al.
European Journal of Public Health|August 27, 2009
Reduction of smoking in Dutch adolescents over the past decade and its health gains: a repeated cross-sectional studyCindy M Gielkens-Sijstermans, Monique A Mommers, Rudolf T Hoogenveen, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 16, 2025
Conceptualization of a decision-analytic model in youth mental health: an application of stakeholder engagement in model development in the NetherlandsHendrika J Valkenburg, Maartje Vriens, Dwayne Meijnckens, et al.
Pharmacoeconomics|September 17, 2008
Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions?David R Rappange, Pieter H M van Baal, N Job A van Exel, et al.
Journal of Affective Disorders|September 15, 2018
The cost-utility of stepped-care algorithms according to depression guideline recommendations - Results of a state-transition model analysisJolanda A C Meeuwissen, Talitha L Feenstra, Filip Smit, et al.
European Journal of Public Health|January 5, 2019
Estimating disease prevalence from drug utilization data using the Random Forest algorithmLaurentius C J Slobbe, Koen Füssenich, Albert Wong, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Scientific Reports|September 2, 2016
Projecting the COPD population and costs in England and Scotland: 2011 to 2030Susannah McLean, Martine Hoogendoorn, Rudolf T Hoogenveen, et al.
BMC Primary Care|June 11, 2024
Effects of a multicomponent communication training to involve older people in decisions to DEPRESCRIBE cardiometabolic medication in primary care (CO-DEPRESCRIBE): protocol for a cluster randomized controlled trial with embedded process and economic evaluationPeter J C Stuijt, Mette Heringa, Liset van Dijk, et al.
Breast (Edinburgh, Scotland)|March 25, 2019
Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? - A cost-effectiveness analysisXuan-Anh Phi, Marcel J W Greuter, Inge-Marie Obdeijn, et al.
Cost Effectiveness and Resource Allocation : C/E|October 7, 2011
Targeted versus universal prevention. a resource allocation model to prioritize cardiovascular preventionTalitha L Feenstra, Pieter M van Baal, Monique O Jacobs-van der Bruggen, et al.
Pharmacoeconomics|June 21, 2024
Evaluating the Cost-Utility of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Systematic Review of the Methods and Quality of Studies Using Decision Models or Empirical DataLisa A de Jong, Xinyu Li, Sajad Emamipour, et al.
European Journal of Public Health|August 27, 2009
Reduction of smoking in Dutch adolescents over the past decade and its health gains: a repeated cross-sectional studyCindy M Gielkens-Sijstermans, Monique A Mommers, Rudolf T Hoogenveen, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 16, 2025
Conceptualization of a decision-analytic model in youth mental health: an application of stakeholder engagement in model development in the NetherlandsHendrika J Valkenburg, Maartje Vriens, Dwayne Meijnckens, et al.
Pharmacoeconomics|September 17, 2008
Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions?David R Rappange, Pieter H M van Baal, N Job A van Exel, et al.
Journal of Affective Disorders|September 15, 2018
The cost-utility of stepped-care algorithms according to depression guideline recommendations - Results of a state-transition model analysisJolanda A C Meeuwissen, Talitha L Feenstra, Filip Smit, et al.
European Journal of Public Health|January 5, 2019
Estimating disease prevalence from drug utilization data using the Random Forest algorithmLaurentius C J Slobbe, Koen Füssenich, Albert Wong, et al.
Pageof 8